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Floating thoracic aortic thrombus in “protein S”
deficient patient
a b cTuncay Hazirolan, MD, Bruce A. Perler, MD, and David A. Bluemke, MD, PhD, Baltimore, MdA 52-year-old woman with known protein S deficiency, insulin-dependent diabe-
tes, bilateral lower-extremity and upper-extremity deep venous thrombosis, and
hypertension presented with new onset of chest pain. A computed tomography scan
was obtained and revealed an aortic mass, possibly an aortic thrombus. The patient
was treated with warfarin but continued to experience episodes of chest pain.
Transesophageal echocardiography revealed a slender polyp-like lesion with a stalk
floating free within the normal descending aorta. By using torso and transesophageal
coils, magnetic resonance (MR) imaging and MR angiography were performed. MR
angiography (Cover) showed an approximately 3  0.8-cm slender polypoid lesion
attached to the wall of the thoracic aorta approximately 3 cm distal to the left
subclavian artery. The MR angiography images were reformatted to depict the mass as
viewed from the inside of the aorta, showing the attachment of the mass to the aortic
wall viewed from below (A) as well as above (B). Cine images (available online)
demonstrate the lesion floating freely within the descending aorta. Delayed postcon-
trast images demonstrate intense enhancement of the mass (C, arrow). The small
arrowheads point to the aorta, and the small arrow points to the transesophageal coil.
After six weeks of heparin treatment, a repeat MR scan showed that the morphol-
ogy and size of the mass was unchanged. Due to the failure to respond to formal
anticoagulant therapy, the patient underwent elective surgery for resection of the
mass. Through a longitudinal aortotomy, a long, dense, sessile mass (D) was easily
teased free from the aorta and separated from its origin.
Most patients with floating aortic thrombus are elderly with diffuse atheroscle-
rotic disease and ulcerated plaque as an attachment point for the thrombus. Floating
thrombus in the thoracic aorta is very rare: approximately 100 cases have been
described.1
The risk of embolic events from mobile versus immobile thrombus is reported as
73%, and 12% respectively.2 Because of the high risk of embolic potential of mobile
thrombus, definitive treatment is necessary. Thrombolysis, anticoagulant therapy, and
surgery have been used as treatment with variable success. One approach is to start
treatment with 2 to 3 weeks of short-term anticoagulation with heparin or low-
molecular-weight heparin. If imaging shows disappearance of the thrombus, heparin
is discontinued and chronic warfarin is initiated. If short-term heparin therapy fails,
surgical thrombectomy is used. Patients will require long-term anticoagulation ther-
apy with coumarin even after successful medical or surgical treatment of floating
thrombus.2
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